Lifecore Biomedical Inc
NASDAQ:LFCR

Watchlist Manager
Lifecore Biomedical Inc Logo
Lifecore Biomedical Inc
NASDAQ:LFCR
Watchlist
Price: 7.67 USD 0.92% Market Closed
Market Cap: 282.5m USD
Have any thoughts about
Lifecore Biomedical Inc?
Write Note

Lifecore Biomedical Inc
Short-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Lifecore Biomedical Inc
Short-Term Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Short-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
Lifecore Biomedical Inc
NASDAQ:LFCR
Short-Term Debt
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Hershey Co
NYSE:HSY
Short-Term Debt
$1.2B
CAGR 3-Years
43%
CAGR 5-Years
-1%
CAGR 10-Years
6%
General Mills Inc
NYSE:GIS
Short-Term Debt
$264.3m
CAGR 3-Years
-38%
CAGR 5-Years
-28%
CAGR 10-Years
-19%
Kellogg Co
NYSE:K
Short-Term Debt
$124m
CAGR 3-Years
-37%
CAGR 5-Years
-8%
CAGR 10-Years
-19%
Kraft Heinz Co
NASDAQ:KHC
Short-Term Debt
$13m
CAGR 3-Years
135%
CAGR 5-Years
-3%
CAGR 10-Years
N/A
Mondelez International Inc
NASDAQ:MDLZ
Short-Term Debt
$1.5B
CAGR 3-Years
85%
CAGR 5-Years
-15%
CAGR 10-Years
-2%
No Stocks Found

Lifecore Biomedical Inc
Glance View

Market Cap
282.5m USD
Industry
Food Products

Lifecore Biomedical, Inc. engages in the design, development, manufacture, and sale of health and wellness products for food and biomaterials markets. The company is headquartered in Chaska, Minnesota and currently employs 689 full-time employees. The firm offers highly differentiated capabilities in the development, fill and finish of complex sterile injectable pharmaceutical products in syringes and vials, as well as the manufacture of pharmaceutical-grade Hyaluronic Acid. The company provides complete CDMO services for injectable pharmaceuticals and medical devices. The Company’s services include sodium hyaluronate, development, manufacturing, and analytical services. The company offers a range of average molecular weights and custom modifications for research and development (R&D), clinical, and commercial applications. The Company’s therapeutic applications include drug delivery, biomaterials, ophthalmology, orthopedics, aesthetics, oncology, and pain management. Its development capabilities include formulation, sterile filtration, filling, packaging, testing, and secondary sterilization.

LFCR Intrinsic Value
10.95 USD
Undervaluation 30%
Intrinsic Value
Price

See Also

What is Lifecore Biomedical Inc's Short-Term Debt?
Short-Term Debt
0 USD

Based on the financial report for Aug 25, 2024, Lifecore Biomedical Inc's Short-Term Debt amounts to 0 USD.

Back to Top